These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1654050)

  • 21. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE; Adachi K; Morgan AR
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
    Beck WT; Danks MK
    Semin Cancer Biol; 1991 Aug; 2(4):235-44. PubMed ID: 1655118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-molecule study of DNA unlinking by eukaryotic and prokaryotic type-II topoisomerases.
    Charvin G; Bensimon D; Croquette V
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9820-5. PubMed ID: 12902541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of human topoisomerase II alpha affecting multidrug resistance and sensitivity.
    Mao Y; Yu C; Hsieh TS; Nitiss JL; Liu AA; Wang H; Liu LF
    Biochemistry; 1999 Aug; 38(33):10793-800. PubMed ID: 10451375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalytic transformations of supercoiled DNA as studied by flow linear dichroism technique.
    Gabibov A; Yakubovskaya E; Lukin M; Favorov P; Reshetnyak A; Monastyrsky M
    FEBS J; 2005 Dec; 272(24):6336-43. PubMed ID: 16336270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.
    Burden DA; Osheroff N
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):139-54. PubMed ID: 9748545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA gyrase: structure and function.
    Reece RJ; Maxwell A
    Crit Rev Biochem Mol Biol; 1991; 26(3-4):335-75. PubMed ID: 1657531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA topoisomerase II, genotoxicity, and cancer.
    McClendon AK; Osheroff N
    Mutat Res; 2007 Oct; 623(1-2):83-97. PubMed ID: 17681352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eukaryotic topoisomerase II cleavage is independent of duplex DNA conformation.
    Choi IY; Chung IK; Muller MT
    Biochim Biophys Acta; 1995 Nov; 1264(2):209-14. PubMed ID: 7495865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Biological functions of DNA topoisomerases].
    Andoh T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1543-9. PubMed ID: 1651680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-molecule measurements of the opening and closing of the DNA gate by eukaryotic topoisomerase II.
    Smiley RD; Collins TR; Hammes GG; Hsieh TS
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4840-5. PubMed ID: 17360343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA topoisomerase II: a review of its involvement in chromosome structure, DNA replication, transcription and mitosis.
    Anderson HJ; Roberge M
    Cell Biol Int Rep; 1992 Aug; 16(8):717-24. PubMed ID: 1332830
    [No Abstract]   [Full Text] [Related]  

  • 34. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.
    Fortune JM; Osheroff N
    Prog Nucleic Acid Res Mol Biol; 2000; 64():221-53. PubMed ID: 10697411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA topoisomerases: enzymes that control DNA conformation.
    Vosberg HP
    Curr Top Microbiol Immunol; 1985; 114():19-102. PubMed ID: 2986908
    [No Abstract]   [Full Text] [Related]  

  • 36. [DNA-topoisomerases and their functions in cell].
    Giliarov DA; Shkundina IS
    Mol Biol (Mosk); 2012; 46(1):52-63. PubMed ID: 22642101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA topology: feeling the pulse of a topoisomerase.
    Stasiak A
    Curr Biol; 2000 Jul; 10(14):R526-8. PubMed ID: 10898993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological regulation of eukaryotic topoisomerase II.
    Isaacs RJ; Davies SL; Sandri MI; Redwood C; Wells NJ; Hickson ID
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):121-37. PubMed ID: 9748535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and regulatory characteristics of eukaryotic type II DNA topoisomerase.
    Bakshi RP; Galande S; Muniyappa K
    Crit Rev Biochem Mol Biol; 2001; 36(1):1-37. PubMed ID: 11256504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic proofreading can explain the supression of supercoiling of circular DNA molecules by type-II topoisomerases.
    Yan J; Magnasco MO; Marko JF
    Phys Rev E Stat Nonlin Soft Matter Phys; 2001 Mar; 63(3 Pt 1):031909. PubMed ID: 11308680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.